| Factor Information | |
|---|---|
| Data ID | 2089 |
| Factor | neutrophil gelatinase-associated lipocalin(NGAL)-before operation |
| Description | N/A |
| Biomarker | YES |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | children with PH-CHD |
| p Value | <0.05 |
| Conclusion | The severe PH group had significantly higher serum NGAL level than the moderate PH group before operation. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 581 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | ASD/VSD/PDA, ASD/VSD |
| Reference | |
|---|---|
| PMID | 24131832 |
| Year | 2013 |
| Title | Perioperative change in serum neutrophil gelatinase-associated lipocalin level among children with congenital heart disease and pulmonary hypertension |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | blood | |
| Region | Xinjiang, China | |
| Method | t-test | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | cardiac surgery | |
| Group | severe PH(Treatment) | moderate PH(Control) |
| Number | 20 | 20 |
| Age | 2.9±1.6 years | 5.4±3.5 years |
| Gender (Male: Female) | 12:8 | 7:13 |
| Marker Level | 86.0±6.2 μg/L | 68.0±14.0 μg/L |
